Clinical Trial Update: Safety and Immunogenicity of Cat-allergen Intralymphatic Immunotherapy in Patients With Cat Allergy With and Without Asthma [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial evaluates the safety and immunogenicity of cat-allergen intralymphatic immunotherapy in individuals with cat allergy, with and without asthm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Asthma

Drugs mentioned

• Cat-allergen intralymphatic immunotherapy

Snippet

Sponsor: University of Zurich | Conditions: Allergic Rhinitis, Allergic Asthma | Phase 1, Phase 2 | Status: RECRUITING